Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
- Conditions
- Lymphoma, Non-Hodgkin
- Registration Number
- NCT00045877
- Lead Sponsor
- Chiron Corporation
- Brief Summary
The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have previously failed Rituxan treatments.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (54)
University of Arkansas for Medical Sciences
🇺🇸Little Rock, Arkansas, United States
Comprehensive Blood and Cancer Center
🇺🇸Bakersfield, California, United States
California Oncology of the Central Valley
🇺🇸Fresno, California, United States
Virginia K. Crosson Cancer Center
🇺🇸Fullerton, California, United States
Pacific Shores Medical Group
🇺🇸Los Alamitos, California, United States
Wilshire Oncology Medical Group
🇺🇸West Covina, California, United States
California Cancer Care Inc.
🇺🇸Greenbrae, California, United States
Santa Barbara Hematology Oncology Medical Group
🇺🇸Solvang, California, United States
UCLS Medical Center
🇺🇸Los Angeles, California, United States
Facey Medical Foundation
🇺🇸Mission Hills, California, United States
Scroll for more (44 remaining)University of Arkansas for Medical Sciences🇺🇸Little Rock, Arkansas, United States